Plaintiff

Neurelis, Inc.

5 cases as plaintiff.

Cases: 5
Active: 5; 0 closed
Filed: 2024–2026
Top venue: D. Delaware; 5 cases

Also appears as a defendant in 3 cases → View as defendant

Watchlist

Get alerted when Neurelis, Inc. sues again.

Email-only, free, anonymous. We'll notify you when Neurelis, Inc. files another patent-infringement lawsuit. One-click unsubscribe from any alert.

Filing activity

Cases filed per year with Neurelis, Inc. as plaintiff.

Neurelis, Inc. v. Strides Pharma Global PTE Ltd. et al.

pending

Docket:: 1:26-cv-00947-MN
Court:: U.S. District Court for the District of Delaware
Filed:: 2026-07-31

Patents:11241414

π Neurelis, Inc.Δ Strides Pharma Global PTE Ltd.Δ Strides Pharma Inc.

ANDA case against Strides relating to ANDA No. 221329 and identified as a related action consolidated under lead case 1:24-cv-00562-MN. The Strides complaint expressly asserts the '414 patent among the asserted patents.

Neurelis, Inc. v. Strides Pharma Global PTE Limited et al.

active

Docket:: 1:26-cv-00947
Court:: U.S. District Court for the District of Delaware
Filed:: 2026-07-31

Patents:11793786 11241414 12268664 12324852 12337061 12521400 12599611

π Neurelis, Inc.Δ Strides Pharma Global PTE Limited Δ Strides Pharma, Inc.

ANDA case against Strides over diazepam nasal spray under Strides ANDA No. 221329; coordinated with the consolidated VALTOCO ANDA actions.

Neurelis, Inc. v. Amneal Pharmaceuticals LLC

pending

Docket:: 1:26-cv-00261-MN
Court:: U.S. District Court for the District of Delaware
Filed:: 2026-03-11

Patents:11241414 12324852 12337061

π Neurelis, Inc.Δ Amneal Pharmaceuticals LLC

ANDA case against Amneal concerning Amneal's ANDA No. 219109 products. The complaint analysis identifies the '414 patent and related family members such as the '852 and '061 patents, and the case is consolidated with the lead Delaware action.

Neurelis, Inc. v. Padagis LLC et al.

pending

Docket:: 1:24-cv-00562-MN
Court:: U.S. District Court for the District of Delaware
Filed:: 2024-05-08

Patents:11241414 8895546 11793786 12268664 12324852 12337061 12521400

π Neurelis, Inc.Δ Padagis LLC Δ Padagis US LLC Δ Padagis Israel Pharmaceuticals Ltd.

ANDA/Hatch-Waxman litigation over Padagis ANDA No. 219320 for generic diazepam nasal spray. It is the lead consolidated action and asserts the '414 patent along with related family patents. Trial is scheduled as a bench trial beginning March 1, 2027.

Neurelis, Inc. v. Lupin Inc.

pending

Docket:: 1:25-cv-01443-MN
Court:: U.S. District Court for the District of Delaware

Patents:11241414

π Neurelis, Inc.Δ Lupin Inc.

Named as a related consolidated ANDA action under lead case 1:24-cv-00562-MN. The narrative groups these dockets in the same patent family and as likely asserting the '414 patent, but provides no separate patent list for this docket.